Jill Rafalko

10PUBLICATIONS
19CO-AUTHORS
Epidemiological modellingLiquid biopsiesGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 10, 2026
Short-Term Risk Stratification in Alcohol-Associated Hepatitis: Small HDL Particles and Inflammation Vulnerability Index Values Improve Model for End-Stage Liver Disease.

|Dec 27, 2023
Next-generation sequencing-based liquid biopsy may be used for detection of residual disease and cancer recurrence monitoring in dogs.

Angela L McCleary-Wheeler, Patrick C Fiaux, Brian K Flesner

|Jul 28, 2023
Detection of Age-Related Somatic Alterations in Canine Blood Using Next-Generation Sequencing-Based Liquid Biopsy: An Analysis of over 4800 Dogs.

Kristina M Kruglyak, Allison L O'Kell, Todd A Cohen

|Feb 01, 2023
Age at cancer diagnosis by breed, weight, sex, and cancer type in a cohort of more than 3,000 dogs: Determining the optimal age to initiate cancer screening in canine patients.

Jill M Rafalko, Kristina M Kruglyak, Angela L McCleary-Wheeler

|Jan 20, 2023
Cancer detection in clinical practice and using blood-based liquid biopsy: A retrospective audit of over 350 dogs.

Andi Flory, Lisa McLennan, Betsy Peet

|Apr 26, 2022
Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.

Andi Flory, Kristina M Kruglyak, John A Tynan

Pageof 2

Frequent Collaborators

3 joint publications

Daniel S Grosu

3 joint publications

Jason Chibuk

2 joint publications

Brenda L Coomber

1 joint publications

Samantha Caldwell